Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Fecal micr...

Full description

Saved in:
Bibliographic Details
Published inMolecular medicine (Cambridge, Mass.) Vol. 25; no. 1; pp. 35 - 16
Main Authors Ma, Yiyangzi, Xu, Xiaoxue, Li, Mengtao, Cai, Jun, Wei, Qiang, Niu, Haitao
Format Journal Article
LanguageEnglish
Published England BioMed Central 01.08.2019
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR). The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes. SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice.
AbstractList Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Methods Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients’ colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR). Results The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes. Conclusions SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved.OBJECTIVESSystemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved.Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR).METHODSFecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR).The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes.RESULTSThe fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes.SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice.CONCLUSIONSSLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR). The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes. SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice.
Abstract Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Methods Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients’ colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR). Results The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes. Conclusions SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice.
ArticleNumber 35
Author Xu, Xiaoxue
Li, Mengtao
Niu, Haitao
Ma, Yiyangzi
Cai, Jun
Wei, Qiang
Author_xml – sequence: 1
  givenname: Yiyangzi
  surname: Ma
  fullname: Ma, Yiyangzi
– sequence: 2
  givenname: Xiaoxue
  surname: Xu
  fullname: Xu, Xiaoxue
– sequence: 3
  givenname: Mengtao
  surname: Li
  fullname: Li, Mengtao
– sequence: 4
  givenname: Jun
  surname: Cai
  fullname: Cai, Jun
– sequence: 5
  givenname: Qiang
  surname: Wei
  fullname: Wei, Qiang
– sequence: 6
  givenname: Haitao
  orcidid: 0000-0003-2210-2051
  surname: Niu
  fullname: Niu, Haitao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31370803$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1r3DAQhkVJaT7aH9BLMfTSi1N9S74USmjTQKCX9iy00nhXi225klzYfx85m5QmkIOQmHnn0TDznqOTKU6A0HuCLwnR8nMmGFPcYtLVg2krXqEzIqhumRT6pL6xki0Rgpyi85z3VUwEF2_QKSNMYY3ZGfLXS2nG4FLchFhsM6c4xgJN2UETpn6w42hLTIcmQZ7jlNfofXK2ZRe3MEEOuYl9kw-5QAU1wzIvuYF0qKq1Ni_5LXrd2yHDu4f7Av3-_u3X1Y_29uf1zdXX29ZJRkurJXOK9JR52xHKKagNF5I71uPO9Qy8Esp2QjvPBGBPuaW4A69tTyQTGLMLdHPk-mj3Zk5htOlgog3mPhDT1thUghvAWI_rRz2xfCO4c2wDynNS2ZgqDtpX1pcja142I3gHU0l2eAJ9mpnCzmzjXyOlqtPXFfDpAZDinwVyMWPIDobBThCXbCiVmmEtOlqlH59J93FJUx2VoYJLjQVTq-rD_x39a-VxmVWgjoK6zZwT9MaFYkuIa4NhMASb1TbmaBtTbWNW2xhRK8mzykf4yzV3gw7GKA
CitedBy_id crossref_primary_10_1177_09612033231155840
crossref_primary_10_3389_fimmu_2020_606936
crossref_primary_10_3389_fimmu_2021_667097
crossref_primary_10_1016_j_heliyon_2024_e37432
crossref_primary_10_1016_j_isci_2023_107122
crossref_primary_10_3389_fimmu_2021_727485
crossref_primary_10_1038_s41522_021_00215_6
crossref_primary_10_3390_ijerph182312836
crossref_primary_10_1016_j_jaut_2023_103109
crossref_primary_10_1186_s12967_020_02539_x
crossref_primary_10_1007_s11926_023_01115_8
crossref_primary_10_3389_fmicb_2020_00628
crossref_primary_10_3389_fmicb_2024_1319654
crossref_primary_10_1093_cei_uxac057
crossref_primary_10_3390_antiox11010084
crossref_primary_10_1039_D1FO00560J
crossref_primary_10_3389_fimmu_2021_796865
crossref_primary_10_3390_ijms24065748
crossref_primary_10_1016_j_clim_2021_108892
crossref_primary_10_3389_fimmu_2023_1202850
crossref_primary_10_1016_j_autrev_2024_103607
crossref_primary_10_1016_j_clim_2022_109109
crossref_primary_10_1016_j_exppara_2024_108863
crossref_primary_10_3390_antiox10091426
crossref_primary_10_1126_scitranslmed_aax2220
crossref_primary_10_7759_cureus_57512
crossref_primary_10_56082_annalsarscibio_2024_2_84
crossref_primary_10_1016_j_molmed_2020_04_001
crossref_primary_10_1007_s11926_023_01102_z
crossref_primary_10_1016_j_coi_2019_08_007
crossref_primary_10_1111_imr_12847
crossref_primary_10_1136_rmdopen_2020_001324
crossref_primary_10_3390_biomedicines12030616
crossref_primary_10_3390_microorganisms13030556
crossref_primary_10_1080_19490976_2023_2247053
crossref_primary_10_3389_fimmu_2020_00282
crossref_primary_10_1080_08916934_2024_2378876
crossref_primary_10_1002_JLB_1MR0321_660R
crossref_primary_10_3390_cells10040785
crossref_primary_10_1007_s11926_021_00986_z
crossref_primary_10_3389_fimmu_2022_1050895
crossref_primary_10_3748_wjg_v28_i18_1875
crossref_primary_10_2174_1381612826666201211114609
crossref_primary_10_3389_fimmu_2022_883747
crossref_primary_10_3390_jpm11070625
crossref_primary_10_3389_fimmu_2023_1228754
crossref_primary_10_2478_rir_2023_0027
crossref_primary_10_1038_s41584_023_01071_8
crossref_primary_10_3389_fphys_2022_1070569
crossref_primary_10_1136_annrheumdis_2021_220687
crossref_primary_10_3390_microorganisms9061132
crossref_primary_10_1002_advs_202201581
crossref_primary_10_1177_09612033231156075
crossref_primary_10_3390_ijms25115608
crossref_primary_10_37349_emed_2022_00112
crossref_primary_10_1007_s11684_022_0957_7
crossref_primary_10_1016_j_micres_2024_127613
crossref_primary_10_3389_fphys_2021_715506
crossref_primary_10_3389_fimmu_2022_897971
crossref_primary_10_1007_s40588_023_00213_6
crossref_primary_10_1016_j_mam_2025_101349
crossref_primary_10_1136_lupus_2022_000776
crossref_primary_10_1016_j_tjnut_2024_01_015
crossref_primary_10_3389_fimmu_2020_01703
crossref_primary_10_3390_biomedicines11123142
crossref_primary_10_3389_fimmu_2024_1365554
crossref_primary_10_1016_j_blre_2024_101252
crossref_primary_10_1177_09612033211025095
crossref_primary_10_1016_j_intimp_2023_109946
crossref_primary_10_1038_s41598_024_77672_4
crossref_primary_10_1186_s12865_024_00632_0
crossref_primary_10_3389_fimmu_2021_615859
crossref_primary_10_3389_fimmu_2020_01741
crossref_primary_10_1080_19490976_2021_1916278
crossref_primary_10_3389_fimmu_2021_686501
crossref_primary_10_3389_fimmu_2023_1120958
crossref_primary_10_1016_j_jchromb_2021_123096
crossref_primary_10_1007_s11894_024_00932_w
crossref_primary_10_1097_BOR_0000000000000993
crossref_primary_10_1111_bph_15512
crossref_primary_10_3389_fimmu_2021_651191
crossref_primary_10_1016_j_autrev_2021_102765
crossref_primary_10_3389_fmicb_2024_1477187
crossref_primary_10_3389_fimmu_2022_954764
Cites_doi 10.1016/j.gpb.2015.09.004
10.1136/gut.2005.073817
10.1146/annurev.immunol.20.100301.064833
10.1038/nmeth.2604
10.1097/BOR.0b013e3283535801
10.1186/s40168-018-0603-4
10.1016/S0163-7258(99)00022-4
10.1128/AEM.02288-17
10.1038/nri2707
10.1111/j.1365-2249.2010.04139.x
10.1042/CS20160415
10.1126/scitranslmed.aan2306
10.1016/j.it.2004.09.005
10.1186/gb-2011-12-6-r60
10.1126/science.1246980
10.1146/annurev.immunol.26.021607.090400
10.1038/nri1572
10.1016/j.cyto.2012.03.003
10.1038/ng.2439
10.3389/fimmu.2015.00610
10.1016/j.clim.2014.12.013
10.1038/ng.3434
10.4049/jimmunol.178.8.4937
10.1084/jem.20090900
10.1016/j.immuni.2014.04.004
10.1136/annrheumdis-2018-214856
10.1038/nprot.2007.315
10.1016/j.tim.2004.01.001
10.3389/fimmu.2018.02307
10.1073/pnas.97.12.6670
10.1016/j.cell.2006.02.017
10.1002/art.40827
10.1007/s11926-017-0695-z
10.1186/s13075-015-0755-6
10.1007/s12016-017-8605-8
10.1016/j.jim.2018.05.014
10.1016/j.chom.2008.09.009
10.1016/j.autrev.2016.07.012
10.4049/jimmunol.1002795
10.1038/s41598-017-14223-0
10.4049/jimmunol.169.5.2694
10.1007/BF02737642
10.4049/jimmunol.173.5.3119
10.1002/ame2.12065
10.1126/science.1104816
10.3892/etm.2014.1578
10.1128/mBio.01548-14
10.1186/s40168-017-0300-8
10.1186/1471-2105-15-14
10.1093/ibd/izy177
10.1056/NEJMra071297
10.1128/AEM.02676-14
10.1186/s40168-019-0683-9
10.1002/eji.200838417
10.1084/jem.20081712
10.4049/jimmunol.162.11.6322
10.1016/j.molcel.2015.05.004
10.1182/blood-2012-05-433755
ContentType Journal Article
Copyright 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The Author(s) 2019
Copyright_xml – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
– notice: The Author(s) 2019
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s10020-019-0102-5
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1528-3658
EndPage 16
ExternalDocumentID oai_doaj_org_article_ad0f23f1a4b54cc3be7d4158c0274e8d
PMC6676588
31370803
10_1186_s10020_019_0102_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: ;
  grantid: 2016-I2M-1-006
– fundername: ;
  grantid: 2017YFA0105204
GroupedDBID ---
-ET
0R~
123
29M
2WC
36B
5RE
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFO
ACMJI
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
IAO
IH2
IHR
ISR
ITC
KQ8
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
RBZ
RNS
ROL
RPM
RSV
SDH
SJN
SOJ
SV3
TR2
UKHRP
WOQ
ACRMQ
C24
M~E
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c632t-863c71f23da91242e7b4564c3f09cf3ed757a958cd35e0d24a209ed8af1635003
IEDL.DBID DOA
ISSN 1076-1551
1528-3658
IngestDate Wed Aug 27 01:29:04 EDT 2025
Thu Aug 21 13:38:34 EDT 2025
Fri Jul 11 09:50:27 EDT 2025
Mon Jun 30 19:23:33 EDT 2025
Thu Jan 02 23:00:09 EST 2025
Thu Apr 24 22:59:44 EDT 2025
Tue Jul 01 01:25:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Fecal microbiota transplantation2
Immune response4
Gut microbiota1
Lupus susceptibility gene5
Systemic lupus erythematosus3
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c632t-863c71f23da91242e7b4564c3f09cf3ed757a958cd35e0d24a209ed8af1635003
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2210-2051
OpenAccessLink https://doaj.org/article/ad0f23f1a4b54cc3be7d4158c0274e8d
PMID 31370803
PQID 2546805372
PQPubID 5066171
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_ad0f23f1a4b54cc3be7d4158c0274e8d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6676588
proquest_miscellaneous_2268308592
proquest_journals_2546805372
pubmed_primary_31370803
crossref_citationtrail_10_1186_s10020_019_0102_5
crossref_primary_10_1186_s10020_019_0102_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-08-01
PublicationDateYYYYMMDD 2019-08-01
PublicationDate_xml – month: 08
  year: 2019
  text: 2019-08-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
– name: London
PublicationTitle Molecular medicine (Cambridge, Mass.)
PublicationTitleAlternate Mol Med
PublicationYear 2019
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References Y Ma (102_CR26) 2015; 13
S Makita (102_CR27) 2007; 178
F Backhed (102_CR3) 2005; 307
H Liu (102_CR24) 2019; 7
H Okada (102_CR41) 2010; 160
S Xiao (102_CR58) 2014; 40
A Hevia (102_CR17) 2014; 5
H Niu (102_CR40) 2008; 38
M Munoz (102_CR38) 2009; 206
T Tamura (102_CR53) 2008; 26
E Mummert (102_CR37) 2018; 459
N Rother (102_CR45) 2015; 6
J Bentham (102_CR6) 2015; 47
H Zhang (102_CR61) 2014; 80
H Bassolas-Molina (102_CR5) 2018; 9
LV Hooper (102_CR18) 2004; 12
E. H. Pieter Dijkhuizen (102_CR55) 2019; 71
M Weidenbusch (102_CR56) 2017; 131
MK Crow (102_CR10) 2014; 192
JD Forbes (102_CR15) 2018; 6
Q Mu (102_CR35) 2017; 7
XX Yu (102_CR60) 2014; 7
RE Ley (102_CR23) 2006; 124
RJ Ball (102_CR4) 2015; 17
C Mohan (102_CR32) 1998; 101
II Ivanov (102_CR19) 2008; 4
D Dembele (102_CR12) 2014; 15
S Makita (102_CR28) 2004; 173
N Segata (102_CR46) 2011; 12
RA Sinico (102_CR51) 2002; 15
C Manichanh (102_CR30) 2006; 55
MT Abreu (102_CR1) 2010; 10
Q Mu (102_CR36) 2017; 5
M Shapiro-Shelef (102_CR48) 2005; 5
B Weigmann (102_CR57) 2007; 2
A Picascia (102_CR42) 2015; 157
KK Unni (102_CR54) 1975; 2
L Morel (102_CR34) 2000; 97
MA Maldonado (102_CR29) 1999; 162
A De Groof (102_CR11) 2017; 53
N Manjarrez-Orduno (102_CR31) 2012; 44
WD Xu (102_CR59) 2012; 58
102_CR25
MA Kleinschek (102_CR21) 2009; 206
JA James (102_CR20) 2012; 24
Y Deng (102_CR13) 2017; 19
NB Blatt (102_CR8) 1999; 83
ES Sobel (102_CR52) 2002; 169
A Rahman (102_CR43) 2008; 358
D Azzouz (102_CR2) 2019; 78
A Montalban-Arques (102_CR33) 2018; 24
O Shamriz (102_CR47) 2016; 15
Teri M. Greiling (102_CR16) 2018; 10
P Brandtzaeg (102_CR9) 2004; 25
JA Reuter (102_CR44) 2015; 58
R Berland (102_CR7) 2002; 20
MN Lee (102_CR22) 2014; 343
GQ Shen (102_CR49) 1998; 16
H Niu (102_CR39) 2013; 121
Na Shi (102_CR50) 2019; 2
RC Edgar (102_CR14) 2013; 10
References_xml – volume: 13
  start-page: 242
  issue: 4
  year: 2015
  ident: 102_CR26
  publication-title: Genomics Proteomics Bioinformatics
  doi: 10.1016/j.gpb.2015.09.004
– volume: 55
  start-page: 205
  issue: 2
  year: 2006
  ident: 102_CR30
  publication-title: Gut.
  doi: 10.1136/gut.2005.073817
– volume: 20
  start-page: 253
  year: 2002
  ident: 102_CR7
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.20.100301.064833
– volume: 10
  start-page: 996
  issue: 10
  year: 2013
  ident: 102_CR14
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2604
– volume: 24
  start-page: 383
  issue: 4
  year: 2012
  ident: 102_CR20
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0b013e3283535801
– volume: 6
  start-page: 221
  issue: 1
  year: 2018
  ident: 102_CR15
  publication-title: Microbiome.
  doi: 10.1186/s40168-018-0603-4
– volume: 101
  start-page: 1362
  issue: 6
  year: 1998
  ident: 102_CR32
  publication-title: J Clin Invest
– volume: 83
  start-page: 125
  issue: 2
  year: 1999
  ident: 102_CR8
  publication-title: Pharmacol Ther
  doi: 10.1016/S0163-7258(99)00022-4
– ident: 102_CR25
  doi: 10.1128/AEM.02288-17
– volume: 10
  start-page: 131
  issue: 2
  year: 2010
  ident: 102_CR1
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2707
– volume: 160
  start-page: 1
  issue: 1
  year: 2010
  ident: 102_CR41
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2010.04139.x
– volume: 131
  start-page: 625
  issue: 8
  year: 2017
  ident: 102_CR56
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS20160415
– volume: 10
  start-page: eaan2306
  issue: 434
  year: 2018
  ident: 102_CR16
  publication-title: Science Translational Medicine
  doi: 10.1126/scitranslmed.aan2306
– volume: 25
  start-page: 570
  issue: 11
  year: 2004
  ident: 102_CR9
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2004.09.005
– volume: 12
  start-page: R60
  issue: 6
  year: 2011
  ident: 102_CR46
  publication-title: Genome Biol
  doi: 10.1186/gb-2011-12-6-r60
– volume: 343
  start-page: 1246980
  issue: 6175
  year: 2014
  ident: 102_CR22
  publication-title: Science.
  doi: 10.1126/science.1246980
– volume: 26
  start-page: 535
  year: 2008
  ident: 102_CR53
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.26.021607.090400
– volume: 5
  start-page: 230
  issue: 3
  year: 2005
  ident: 102_CR48
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri1572
– volume: 58
  start-page: 317
  issue: 3
  year: 2012
  ident: 102_CR59
  publication-title: Cytokine.
  doi: 10.1016/j.cyto.2012.03.003
– volume: 44
  start-page: 1227
  issue: 11
  year: 2012
  ident: 102_CR31
  publication-title: Nat Genet
  doi: 10.1038/ng.2439
– volume: 6
  start-page: 610
  year: 2015
  ident: 102_CR45
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2015.00610
– volume: 157
  start-page: 1
  issue: 1
  year: 2015
  ident: 102_CR42
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2014.12.013
– volume: 47
  start-page: 1457
  issue: 12
  year: 2015
  ident: 102_CR6
  publication-title: Nat Genet
  doi: 10.1038/ng.3434
– volume: 178
  start-page: 4937
  issue: 8
  year: 2007
  ident: 102_CR27
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.8.4937
– volume: 206
  start-page: 3047
  issue: 13
  year: 2009
  ident: 102_CR38
  publication-title: J Exp Med
  doi: 10.1084/jem.20090900
– volume: 40
  start-page: 477
  issue: 4
  year: 2014
  ident: 102_CR58
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2014.04.004
– volume: 78
  start-page: 947
  issue: 7
  year: 2019
  ident: 102_CR2
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2018-214856
– volume: 2
  start-page: 2307
  issue: 10
  year: 2007
  ident: 102_CR57
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2007.315
– volume: 12
  start-page: 129
  issue: 3
  year: 2004
  ident: 102_CR18
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2004.01.001
– volume: 9
  start-page: 2307
  year: 2018
  ident: 102_CR5
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02307
– volume: 97
  start-page: 6670
  issue: 12
  year: 2000
  ident: 102_CR34
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.97.12.6670
– volume: 124
  start-page: 837
  issue: 4
  year: 2006
  ident: 102_CR23
  publication-title: Cell.
  doi: 10.1016/j.cell.2006.02.017
– volume: 2
  start-page: 36
  issue: 1
  year: 1975
  ident: 102_CR54
  publication-title: J Rheumatol
– volume: 71
  start-page: 1000
  issue: 6
  year: 2019
  ident: 102_CR55
  publication-title: Arthritis & Rheumatology
  doi: 10.1002/art.40827
– volume: 19
  start-page: 68
  issue: 11
  year: 2017
  ident: 102_CR13
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-017-0695-z
– volume: 17
  start-page: 274
  year: 2015
  ident: 102_CR4
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0755-6
– volume: 53
  start-page: 181
  issue: 2
  year: 2017
  ident: 102_CR11
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-017-8605-8
– volume: 459
  start-page: 11
  year: 2018
  ident: 102_CR37
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2018.05.014
– volume: 4
  start-page: 337
  issue: 4
  year: 2008
  ident: 102_CR19
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2008.09.009
– volume: 15
  start-page: 859
  issue: 9
  year: 2016
  ident: 102_CR47
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2016.07.012
– volume: 192
  start-page: 5459
  issue: 12
  year: 2014
  ident: 102_CR10
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1002795
– volume: 7
  start-page: 13675
  issue: 1
  year: 2017
  ident: 102_CR35
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-14223-0
– volume: 169
  start-page: 2694
  issue: 5
  year: 2002
  ident: 102_CR52
  publication-title: J Immunol
  doi: 10.4049/jimmunol.169.5.2694
– volume: 16
  start-page: 321
  issue: 3
  year: 1998
  ident: 102_CR49
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/BF02737642
– volume: 173
  start-page: 3119
  issue: 5
  year: 2004
  ident: 102_CR28
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.5.3119
– volume: 2
  start-page: 98
  issue: 2
  year: 2019
  ident: 102_CR50
  publication-title: Animal Models and Experimental Medicine
  doi: 10.1002/ame2.12065
– volume: 307
  start-page: 1915
  issue: 5717
  year: 2005
  ident: 102_CR3
  publication-title: Science.
  doi: 10.1126/science.1104816
– volume: 7
  start-page: 1135
  issue: 5
  year: 2014
  ident: 102_CR60
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2014.1578
– volume: 5
  start-page: e01548
  issue: 5
  year: 2014
  ident: 102_CR17
  publication-title: MBio.
  doi: 10.1128/mBio.01548-14
– volume: 5
  start-page: 73
  issue: 1
  year: 2017
  ident: 102_CR36
  publication-title: Microbiome.
  doi: 10.1186/s40168-017-0300-8
– volume: 15
  start-page: 14
  year: 2014
  ident: 102_CR12
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-15-14
– volume: 24
  start-page: 1649
  issue: 8
  year: 2018
  ident: 102_CR33
  publication-title: Inflamm Bowel Dis
  doi: 10.1093/ibd/izy177
– volume: 358
  start-page: 929
  issue: 9
  year: 2008
  ident: 102_CR43
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra071297
– volume: 15
  start-page: S20
  issue: Suppl 6
  year: 2002
  ident: 102_CR51
  publication-title: J Nephrol
– volume: 80
  start-page: 7551
  issue: 24
  year: 2014
  ident: 102_CR61
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.02676-14
– volume: 7
  start-page: 68
  issue: 1
  year: 2019
  ident: 102_CR24
  publication-title: Microbiome.
  doi: 10.1186/s40168-019-0683-9
– volume: 38
  start-page: 3028
  issue: 11
  year: 2008
  ident: 102_CR40
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200838417
– volume: 206
  start-page: 525
  issue: 3
  year: 2009
  ident: 102_CR21
  publication-title: J Exp Med
  doi: 10.1084/jem.20081712
– volume: 162
  start-page: 6322
  issue: 11
  year: 1999
  ident: 102_CR29
  publication-title: J Immunol
  doi: 10.4049/jimmunol.162.11.6322
– volume: 58
  start-page: 586
  issue: 4
  year: 2015
  ident: 102_CR44
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2015.05.004
– volume: 121
  start-page: 1986
  issue: 11
  year: 2013
  ident: 102_CR39
  publication-title: Blood.
  doi: 10.1182/blood-2012-05-433755
SSID ssj0021545
Score 2.5444303
Snippet Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose...
Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors....
Abstract Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 35
SubjectTerms Antibodies
Discriminant analysis
Disease
Fecal microbiota transplantation2
Feces
Gene expression
Genomes
Gut microbiota
Gut microbiota1
Hypotheses
Immune response
Immune response4
Immune system
Laboratory animals
Lupus
Lupus susceptibility gene5
Medical research
Microbiota
Pathogenesis
Software
Systemic lupus erythematosus3
Taxonomy
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9UwEA-6IngRv62uEsGTEGyb5qMnUXFdBD258G4hzcf6YLd9vraH_e-dSfre-kT2mqSQTmYyv2QmvyHkbRtliNZyBmC0Y02nIuyDjWfgfbwA_6d9Chd8_yFPz5pvK7FaLtzGJa1ytyemjdoPDu_I3yNvu0bykfrD5jfDqlEYXV1KaNwmd5C6DFO61Or6wIXwIOccSobQYIlqVlri0zk8OJX4hAd8LBMHfinR9_8Pc_6bOvmXLzp5QO4vIJJ-zKv-kNwK_SNyN5eVvHpM_Nd5opfrTLE0WbpJKXeBAtajoFCgA5cptk63OUEWW1MnliceznH3W490iDTTPK8dvZg380jD9ipzvA7jPD4hZydffn4-ZUs1BeYkryemJXeqijX3tgWnXgfVIZWM47FsXeTBK6EsyNB5LkLp68bWZRu8thEgmwDjf0qO-qEPzwlVrWqdtEFyaxsnBGAepywglS5UsnShIOVOlsYtVONY8eLCpCOHliaL34D4DYrfiIK823-yyTwbNw3-hAu0H4gU2alh2J6bxeKM9SX8bKxs04nGOd4F5QGtaIcH8aB9QY53y2sWux3NtZYV5M2-GywOwyi2D8MMY2qpOfLCwZhnWRv2M-EVV4DBeUHUgZ4cTPWwp1__SqzemGwstH5x87Reknt1UlpMQTwmR9N2Dq8AFk3d66T7fwB5mAuF
  priority: 102
  providerName: ProQuest
Title Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus
URI https://www.ncbi.nlm.nih.gov/pubmed/31370803
https://www.proquest.com/docview/2546805372
https://www.proquest.com/docview/2268308592
https://pubmed.ncbi.nlm.nih.gov/PMC6676588
https://doaj.org/article/ad0f23f1a4b54cc3be7d4158c0274e8d
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZtSqGX0vQVp-miQk8FU9uyHj5mSx4EGkpoYOlFyJLcLiT2srYP-fedkbxLtpT2kosP1hjk0UjzDTP6hpCPVSN8YwxLAYzWaVnLBs7B0qXgfRwH_6dcSBd8vRTn1-XFgi_utfrCmrBIDxwV99m4rClYk5uy5qW1rPbSgdNRFuMprxyevuDzNsHUFGohMIjVhiJFUDDlM3Ml8NIchkwZXt4B75ryHY8UiPv_hjb_LJq854VOX5DnE3ykx3Ha--SRb1-Sp7Gh5N0r4s7Ggd4uI7nSYOgqFNt5CiiPginB6t-GrDpdx9JYfBsGsTFx9xPPvWVPu4ZGguelpTfjauypX99FdteuH_vX5Pr05PuX83Tqo5BawYohVYJZmYMWnanAnRde1kgiY1mTVbZh3kkuTQUqdYz7zBWlAY16p0wDYI3Dtn9D9tqu9QeEykpWVhgvmDGl5RzQjpUGMErtc5FZn5Bso0ttJ5Jx7HVxo0OwoYSO6tegfo3q1zwhn7afrCLDxr-E57hAW0Ekxw4vwGT0ZDL6fyaTkKPN8uppx_Ya-wIoJLcpEvJhOwx7DRMopvXdCDKFUAwZ4UDmbbSG7UxYziSgb5YQuWMnO1PdHWmXvwKfN5YZc6UOH-Lf3pFnRTBtLFE8InvDevTvATYN9Yw8lgs5I0_mJ5ffrmZhv8Dzav7jN56AGFA
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwQviG8KA4wEL0gRaRx_5AEhBhsd2yqENmlvxrGdrdLWdE0j1H-Kv5G7OAkUob3tNXYj53zn-13v_DtCXmeF8IUxLAIwmkdpLgs4B1MXgfdxHPyfck264HAixsfp1xN-skF-dXdhsKyyOxObg9qVFv8jf4e87QrJR5IP88sIu0ZhdrVroRHUYt-vfkLIVr3f-wz7-yZJdneOPo2jtqtAZAVLlpESzMpRkTBnMnBuiZc5UqpYVsSZLZh3kkuTcWUd4z52SWqSOPNOmQKgCwcjgPfeIJspg1BmQDa3dybfvvchHgKSUOUoIgQjbR51pARe1sNQLcZLQ-DVI77mCZuGAf9Duf8Wa_7l_XbvkjstbKUfg57dIxt-dp_cDI0sVw-I-1Iv6cU0kDotDZ03RX6eArqkoMKgdRdNNp8uQkkuPm0GsSFyeYrn7bSiZUEDsfTU0vN6XlfUL1aBVbas6uohOb4WST8ig1k5808IlZnMrDBeMGNSyzmgLCsNYKPcj0Rs_ZDEnSy1bcnNscfGuW6CHCV0EL8G8WsUv-ZD8rb_yTwwe1w1eRs3qJ-IpNzNg3Jxqlsb18bF8LHFyKQ5T61luZcO8JGyGPp75YZkq9te3Z4Ulf6j10Pyqh8GG8fEjZn5soY5iVAMmehgzuOgDf1K2IhJQP1sSOSanqwtdX1kNj1reMSxvJkr9fTqZb0kt8ZHhwf6YG-y_4zcThoFxgLILTJYLmr_HEDZMn_RWgIlP67b-H4Db5pIxg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4k2ggJHgghQ1ieNHDggBZWkpVByotDfj2E5Zqd0sm43Q_jV-HTN2dssi1FuvsbPyjufxOTP-hpAXVSN8YwxLAYzWaVnLBvxg6VKIPo5D_FMupAu-HIn94_LTmI-3yO_VXRgsq1z5xOCoXWvxG_ku8rYrJB8pdpuhLOLr3ujN7GeKHaQw07pqpxFV5NAvf8HxrXt9sAd7_bIoRh--vd9Phw4DqRWsWKRKMCvzpmDOVBDoCi9rpFexrMkq2zDvJJem4so6xn3mitIUWeWdMg3AGA4GAb97hVyVjOdoY3J8fthDaBLrHUWKsGTIqOZK4LU9PLRleH0I4nvKN2JiaB3wP7z7b9nmX3FwdIvcHAAsfRs17jbZ8tM75Fpsabm8S9zHfkHPJpHeaWHoLJT7eQo4k4Iyg_6dhbw-ncfiXHwaBrE1cnuCnnfS0bahkWJ6YulpP-s76ufLyC_bdn13jxxfipzvk-1pO_UPCZWVrKwwXjBjSss54C0rDaCk2ucisz4h2UqW2g4059ht41SH444SOopfg_g1il_zhLxavzKLHB8XTX6HG7SeiPTc4UE7P9GDtWvjMvizTW7KmpfWstpLB0hJWfwI4JVLyM5qe_XgMzp9ruEJeb4eBmvHFI6Z-raHOYVQDDnpYM6DqA3rlbCcScD_LCFyQ082lro5Mp38CIziWOjMlXp08bKeketgcvrzwdHhY3KjCPqLlZA7ZHsx7_0TQGeL-mkwA0q-X7bd_QEjzkuW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+microbiota+promote+the+inflammatory+response+in+the+pathogenesis+of+systemic+lupus+erythematosus&rft.jtitle=Molecular+medicine+%28Cambridge%2C+Mass.%29&rft.au=Yiyangzi+Ma&rft.au=Xiaoxue+Xu&rft.au=Mengtao+Li&rft.au=Jun+Cai&rft.date=2019-08-01&rft.pub=BMC&rft.issn=1076-1551&rft.eissn=1528-3658&rft.volume=25&rft.issue=1&rft.spage=1&rft.epage=16&rft_id=info:doi/10.1186%2Fs10020-019-0102-5&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ad0f23f1a4b54cc3be7d4158c0274e8d
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1076-1551&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1076-1551&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1076-1551&client=summon